Cyclin D1 overexpression in multiple myeloma: A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens

American Journal of Clinical Pathology

Volumn 116, Issue 4, 2001, Pages 535-542

  Athanasiou, Evangelia ^a   Kaloutsi, Vassiliki ^a   Kotoula, Vassiliki ^a   Hytiroglou, Prodromos ^a   Kostopoulos, Ioannis ^a   Zervas, Costas ^b   Kalogiannidis, Panagiotis ^c   Fassas, Athanasios ^c   Christakis, John I ^b   Papadimitriou, Constantine S ^a,d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c G PAPANICOLAOU HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Cyclin D1; Immunohistochemistry; In situ hybridization; Multiple myeloma; Paraffin embedded bone marrow biopsy specimens

Indexed keywords

BIOTIN; CYCLIN D1; MESSENGER RNA;

ARTICLE; BONE MARROW BIOPSY; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ANTIGENS, CD20; BIOPSY; BIOTINYLATION; BONE MARROW; CELL DIFFERENTIATION; CYCLIN D1; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PARAFFIN; PLASMA CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE EMBEDDING;

EID: 18344380811     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/BVT4-YP41-LCV2-5GT0     Document Type: Article

References (41)

1. Nishida K, Tamura A, Nakazawa N, et al. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood. 1997;90:526-534.
2. Bergsagel PL, Chesi M, Nardini E, et al. Promiscuous translocations into immunoglobulin heavy chain switch regions. Proc Natl Acad Sci U S A. 1996;93:13931-13936.
3. Finelli P, Fabris S, Zagano S, et al. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization. Blood. 1999;94:724-732.
4. Ronchetti D, Finelli P, Richelda R, et al. Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood. 1999;93:1330-1337.
5. Chesi M, Bergsagel PL, Shonukan OO, et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood. 1998;91:4457-4463.
6. Chesi M, Nardini E, Brents LA, et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet. 1997;16:260-264.
7. Chesi M, Bergsagel PL, Brents LA, et al. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood. 1996;88:674-681.
8. Tricot G, Barlogie B, Jagannath S, et al. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood. 1995;86:4250-4256.
9. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol. 1998;51:1-7.
10. Nagata D, Suzuki E, Nishimatsu H, et al. Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells. J Biol Chem. 2001;276:662-669.
11. Uchimaru K, Taniguchi T, Yoshikawa M, et al. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood. 1997;89:965-974.
12. Bartkova J, Lukas J, Strauss M, et al. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol. 1994;172:237-245.
13. Vasef MA, Medeiros LJ, Yospur LS, et al. Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod Pathol. 1997;10:927-932.
14. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood. 1991;78:493-498.
15. Fonseca R, Witzig TE, Gertz MA, et al. Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases. Br J Haematol. 1998;101:296-301.
16. Lai JL, Michaux L, Dastugue N, et al. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant. Cancer Genet Cytogenet. 1998;104:133-138.
17. Schaefer HE. How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K, Hübner K, eds. Pathology of the Bone Marrow. Stuttgart, Germany: Gustav Fischer Verlag; 1984:6-9.
18. Durie BG, Salmon SE. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842-854.
19. Sailer M, Vykoupil KF, Peest D, et al. Prognostic relevance of a histologie classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients. Eur J Haematol. 1995;54:137-146.
20. Lai R, Medeiros LJ, Wilson CS, et al. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity. Mod Pathol. 1998;11:642-647.
21. Pruneri G, Fabris S, Baldini L, et al. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol. 2000;156:1505-1513.
22. Furukawa Y, Kikuchi J, Nakamura M, et al. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation. Br J Haematol. 2000;110:663-673.
23. Williams ME, Nichols GE, Swerdlow SH, et al. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma. Ann Oncol. 1995;6:297-299.
24. Athanasiou E, Kotoula V, Hytiroglou P, et al. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues. Mod Pathol. 2001;14:62-71.
25. Taniguchi T, Fujita A, Takahashi S, et al. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies. Jpn J Cancer Res. 1998;89:159-166.
26. Sonoki T, Hata H, Kuribayashi N, et al. Expression of PRAD1/cyclin D1 in plasma cell malignancy: incidence and prognostic aspects. Br J Haematol. 1999;104:614-617.
27. Kawano MM, Mahmoud MS, Ishikawa H. Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively. Br J Haematol. 1997;99:131-138.
28. Gaulier A, Fourcade C, Szekeres G, et al. Bone marrow one step fixation-decalcification in Lowy FMA solution: an immunohistological and in situ hybridization study. Pathol Res Pract. 1994;190:1149-1161.
29. Roncaroli F, Dina R, Geuna M, et al. Identification of granulocyte-macrophage colony stimulating factor receptor mRNA by non-isotopic in situ hybridization in bone marrow biopsies. Hoematologica. 1994;79:322-327.
30. Erber WN, Asbahr HD, Phelps PN. In situ hybridization of immunoglobulin light chain mRNA on bone marrow trephines using biotinylated probes and the APAAP method. Pathology. 1993;25:63-67.
31. Sasaki J, Nomura T, Watanabe S, et al. The expression of actin mRNA in megakaryocytes demonstrated in paraffin sections, and epoxy resin semi-thin and thin sections by in situ hybridization. J Electron Microsc (Tokyo). 1991;40:118-123.
32. Hoyer JD, Hanson CA, Fonseca R, et al. The (11;14)(q13;q32) translocation in multiple myeloma: a morphologic and immunohistochemical study. Am J Clin Pathol. 2000;113:831-837.
33. Vos CB, Ter Haar NT, Peterse JL, et al. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J Pathol. 1999;187:279-284.
34. Hoechtlen-Vollmar W, Menzel G, Bartl R, et al. Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance. Br J Haematol. 2000;109:30-38.
35. McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogens. 1995;11:885-891.
36. Hunter T, Pines J. Cyclins and cancer, II: cyclin D and CDK inhibitors come of age. Cell. 1994;79:573-582.
37. Sola B, Salaun V, Ballet JJ, et al. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders. Int J Cancer. 1999;83:230-234.
38. Thuneke I, Schulte HM, Bamberger AM. Biphasic effect of medroxyprogesterone-acetate (MPA) treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells. Breast Cancer Res Treat. 2000;63:243-248.
39. Arber N, Doki Y, Han EK, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 1997;57:1569-1574.
40. Ligueras M, Jeoung D, Tang B, et al. Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. Br J Cancer. 1997;76:21-28.
41. Feinman R, Sawyer J, Hardin J, et al. Cytogenetics and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am. 1997;11:1-25.